Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)

NCT02556411 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Adenomyosis
Chronic Pelvic Pain

Interventions

DRUG: LNG-IUS 13,5 mg Levonorgestrel
DRUG: Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg

Sponsor

University of Cagliari